Device
S.M.A.R.T CONTROL Stent
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
1
50%
Ph phase_4
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
withdrawn150%
unknown150%
Recent Activity
0 active trials
Showing 2 of 2
withdrawnnot_applicable
Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease
NCT01570803
unknownphase_4
Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease
NCT01653600
Clinical Trials (2)
Showing 2 of 2 trials
NCT01570803Not Applicable
Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease
NCT01653600Phase 4
Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2